Trademarkia Logo

Australia

AU$
Trademark Search
SIMTRA BIOPHARMA SOLUTIONS

View On IPO.GOV.AU

SIMTRA BIOPHARMA SOLUTIONS
Protected: Registered/protected

Last updated on 16 Apr 2024

Owner Info

BAMBOO US BIDCO LLC

450 Lexington Ave.

New York NY 10017, UNITED STATES OF AMERICA

Serial Number

2415655 filed on 29 Sept 2023

Correspondent

KNOBBE MARTENS OLSON & BEAR LLP c/o Salima Merani and Jonathan Menkes

2040 Main Street, 14th Floor,

Irvine CA 92614,

UNITED STATES OF AMERICA

SIMTRA BIOPHARMA SOLUTIONS

Classification Information

Class [001]
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, infectious diseases, immune disorders, infertility, vir Read More

Class [005]
Dermatologicals; inhalers for medical purposes, sold filled with pharmaceutical preparations for treating respiratory disorders, infectious disorders, Read More

Class [040]
Custom manufacture of pharmaceuticals; custom manufacturing services for others in the field of pharmaceuticals; providing technical information in th Read More

Class [042]
Consulting services in the field of pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical products develop Read More

Class [044]
Pharmaceutical advice; pharmaceutical compounding services; providing medical information to manufacturers in the form of reports for manufacturing of Read More

Mark Details

Serial Number

2415655

Registered On

29 Sept 2023

Renewal On

29 Sept 2033

Mark Type

WORD

Priority Claim (Convention Details)

Date

7 Sept 2023

Mark Type

US

Legal History

Show more

Status DateAction Taken
16th Apr 2024International Registration in Australia Protected correspondence sent
15th Apr 2024International Registration in Australia Protected correspondence sent
15th Apr 2024IP Right Registration Published
15th Apr 2024Status change to Registered/Protected
8th Feb 2024Customer Amendment Made correspondence sent
8th Feb 2024Amendment to Address for Service Requested
8th Feb 2024Application Accepted correspondence sent
8th Feb 2024IP Right has been Examined
8th Feb 2024IP Right Acceptance Published
2th Jan 2024Status change to Accepted